HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

MDX 060

in phase I/II clinical trials for treatment of CD30+ lymphomas
Also Known As:
5F11 monoclonal antibody; MDX-060; MDX060
Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Engert, Andreas: 1 article (07/2007)
2. Fischkoff, Steven: 1 article (07/2007)
3. Lin, Thomas: 1 article (07/2007)
4. Borchmann, Peter: 1 article (07/2007)
5. Ansell, Stephen M: 1 article (07/2007)
6. Horwitz, Steven M: 1 article (07/2007)
7. Assad, Albert: 1 article (07/2007)
8. Graziano, Robert: 1 article (07/2007)
9. Khan, Khuda Dad: 1 article (07/2007)
10. Keler, Tibor: 1 article (07/2007)

Related Diseases

1. Lymphoma (Lymphomas)
2. Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
3. Neoplasms (Cancer)
4. Hodgkin Disease (Hodgkin's Disease)

Related Drugs and Biologics

1. Immunoglobulins (Immunoglobulin)
2. Antigens
3. Antibodies
4. siplizumab
5. CMC544 (Inotuzumab Ozogamicin)
6. hLL2 agent (epratuzumab)
7. galiximab
8. alemtuzumab (Campath)